FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2500260037> ?p ?o ?g. }

• W2500260037 endingPage "190" @default.
• W2500260037 startingPage "190" @default.
• W2500260037 abstract "We hypothesized that lower proportion of serum phospholipid docosahexaenoic acid (DHA) is inversely associated with increased cardiovascular risk and vascular function in metabolically healthy men. To elucidate it, we first compared serum phospholipid free fatty acid (FA) compositions and cardiovascular risk parameters between healthy men (n = 499) and male patients with coronary artery disease (CAD, n = 111) (30-69 years) without metabolic syndrome, and then further-analyzed the association of serum phospholipid DHA composition with arterial stiffness expressed by brachial-ankle pulse wave velocity (ba-PWV) in metabolically healthy men. Basic parameters, lipid profiles, fasting glycemic status, adiponectin, high sensitivity C-reactive protein (hs-CRP) and LDL particle size, and serum phospholipid FA compositions were significantly different between the two subject groups. Serum phospholipid DHA was highly correlated with most of long-chain FAs. Metabolically healthy men were subdivided into tertile groups according to serum phospholipid DHA proportion: lower (< 2.061%), middle (2.061%-3.235%) and higher (> 3.235%). Fasting glucose, insulin resistance, hs-CRP and ba-PWVs were significantly higher and adiponectin and LDL particle size were significantly lower in the lower-DHA group than the higher-DHA group after adjusted for confounding factors. In metabolically healthy men, multiple stepwise regression analysis revealed that serum phospholipid DHA mainly contributed to arterial stiffness (β'-coefficients = -0.127, p = 0.006) together with age, systolic blood pressure, triglyceride (r = 0.548, p = 0.023). Lower proportion of serum phospholipid DHA was associated with increased cardiovascular risk and arterial stiffness in metabolically healthy men. It suggests that maintaining higher proportion of serum phospholipid DHA may be beneficial for reducing cardiovascular risk including arterial stiffness in metabolically healthy men." @default.
• W2500260037 created "2016-08-23" @default.
• W2500260037 creator A5009340162 @default.
• W2500260037 creator A5060171549 @default.
• W2500260037 creator A5062870666 @default.
• W2500260037 creator A5077006752 @default.
• W2500260037 date "2016-01-01" @default.
• W2500260037 modified "2023-09-26" @default.
• W2500260037 title "Serum Phospholipid Docosahexaenoic Acid Is Inversely Associated with Arterial Stiffness in Metabolically Healthy Men" @default.
• W2500260037 cites W1778645648 @default.
• W2500260037 cites W1831043359 @default.
• W2500260037 cites W1966039186 @default.
• W2500260037 cites W1974519923 @default.
• W2500260037 cites W1979031630 @default.
• W2500260037 cites W1981534282 @default.
• W2500260037 cites W1994449935 @default.
• W2500260037 cites W1998817533 @default.
• W2500260037 cites W2011076773 @default.
• W2500260037 cites W2011375737 @default.
• W2500260037 cites W2012016664 @default.
• W2500260037 cites W2019417598 @default.
• W2500260037 cites W2020000923 @default.
• W2500260037 cites W2030701048 @default.
• W2500260037 cites W2032169238 @default.
• W2500260037 cites W2047414650 @default.
• W2500260037 cites W2064468000 @default.
• W2500260037 cites W2071428196 @default.
• W2500260037 cites W2074702732 @default.
• W2500260037 cites W2077153457 @default.
• W2500260037 cites W2078472811 @default.
• W2500260037 cites W2082238819 @default.
• W2500260037 cites W2093147244 @default.
• W2500260037 cites W2102171595 @default.
• W2500260037 cites W2105057121 @default.
• W2500260037 cites W2123273468 @default.
• W2500260037 cites W2125914602 @default.
• W2500260037 cites W2139498341 @default.
• W2500260037 cites W2150541210 @default.
• W2500260037 cites W2150721177 @default.
• W2500260037 cites W2154703561 @default.
• W2500260037 cites W2162417391 @default.
• W2500260037 cites W2162909477 @default.
• W2500260037 cites W2166218750 @default.
• W2500260037 cites W2168526937 @default.
• W2500260037 cites W2170375389 @default.
• W2500260037 cites W2596624061 @default.
• W2500260037 cites W4230870013 @default.
• W2500260037 doi "https://doi.org/10.7762/cnr.2016.5.3.190" @default.
• W2500260037 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4967722" @default.
• W2500260037 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27482523" @default.
• W2500260037 hasPublicationYear "2016" @default.
• W2500260037 type Work @default.
• W2500260037 sameAs 2500260037 @default.
• W2500260037 citedByCount "5" @default.
• W2500260037 countsByYear W25002600372017 @default.
• W2500260037 countsByYear W25002600372018 @default.
• W2500260037 countsByYear W25002600372020 @default.
• W2500260037 countsByYear W25002600372022 @default.
• W2500260037 crossrefType "journal-article" @default.
• W2500260037 hasAuthorship W2500260037A5009340162 @default.
• W2500260037 hasAuthorship W2500260037A5060171549 @default.
• W2500260037 hasAuthorship W2500260037A5062870666 @default.
• W2500260037 hasAuthorship W2500260037A5077006752 @default.
• W2500260037 hasBestOaLocation W25002600371 @default.
• W2500260037 hasConcept C126322002 @default.
• W2500260037 hasConcept C134018914 @default.
• W2500260037 hasConcept C19038510 @default.
• W2500260037 hasConcept C2775850156 @default.
• W2500260037 hasConcept C2776782570 @default.
• W2500260037 hasConcept C2777171753 @default.
• W2500260037 hasConcept C2777391703 @default.
• W2500260037 hasConcept C2778163477 @default.
• W2500260037 hasConcept C2778319312 @default.
• W2500260037 hasConcept C2778913445 @default.
• W2500260037 hasConcept C2778918659 @default.
• W2500260037 hasConcept C2779306644 @default.
• W2500260037 hasConcept C2780578515 @default.
• W2500260037 hasConcept C41625074 @default.
• W2500260037 hasConcept C543025807 @default.
• W2500260037 hasConcept C55493867 @default.
• W2500260037 hasConcept C555293320 @default.
• W2500260037 hasConcept C71924100 @default.
• W2500260037 hasConcept C84393581 @default.
• W2500260037 hasConcept C86803240 @default.
• W2500260037 hasConceptScore W2500260037C126322002 @default.
• W2500260037 hasConceptScore W2500260037C134018914 @default.
• W2500260037 hasConceptScore W2500260037C19038510 @default.
• W2500260037 hasConceptScore W2500260037C2775850156 @default.
• W2500260037 hasConceptScore W2500260037C2776782570 @default.
• W2500260037 hasConceptScore W2500260037C2777171753 @default.
• W2500260037 hasConceptScore W2500260037C2777391703 @default.
• W2500260037 hasConceptScore W2500260037C2778163477 @default.
• W2500260037 hasConceptScore W2500260037C2778319312 @default.
• W2500260037 hasConceptScore W2500260037C2778913445 @default.
• W2500260037 hasConceptScore W2500260037C2778918659 @default.
• W2500260037 hasConceptScore W2500260037C2779306644 @default.
• W2500260037 hasConceptScore W2500260037C2780578515 @default.
• W2500260037 hasConceptScore W2500260037C41625074 @default.

• next